Get started
ORPEAORPEAORPEA

ORPEA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

ORP2 chart


Full chart

ORP2 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.82 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪1.35 B‬ EUR
Revenue (FY)
‪5.20 B‬ EUR
Shares float
‪87.02 M‬
Beta (1Y)
1.83

Employees


Employees (FY)
‪78.48 K‬
Change (1Y)
‪+2.32 K‬ +3.04%
Revenue / Employee (1Y)
‪66.23 K‬ EUR
Net income / Employee (1Y)
‪17.27 K‬ EUR

About EMEIS


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Laurent Guillot
Website
emeis-group.com
Headquarters
Puteaux
Founded
1995
ISIN
FR001400NLM4
FIGI
BBG00X8QHBB6
Emeis SA engages in the operation of geriatric healthcare facilities. It operates through the following geographical segments: France Benelux UK Ireland, Central Europe, Eastern Europe, Iberian Peninsula/Latin America, and Others. Its services include nursing homes, psychiatric care clinics, home care, and post-acute and rehabilitation clinics. The company was founded by Jean-Claude Marian in 1989 and is headquartered in Puteaux, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ORP2 news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ORP2 highest yielding bonds


FR0011365634
Orpea 5,25% 04/12/2026
Yield to maturity
5.25%
Maturity date
Dec 4, 2026

See all ORP2 bonds 


Check out other big names from the same industry as ORP2.

Frequently Asked Questions


The current price of ORP2 is 11.460 EUR — it has increased by 2.48% in the past 24 hours. Watch ORPEA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange ORPEA stocks are traded under the ticker ORP2.
ORP2 stock has risen by 3.86% compared to the previous week, the month change is a −3.45% fall, over the last year ORPEA has showed a 5.54% increase.
We've gathered analysts' opinions on ORPEA future price: according to them, ORP2 price has a max estimate of 15.00 EUR and a min estimate of 7.90 EUR. Watch ORP2 chart and read a more detailed ORPEA stock forecast: see what analysts think of ORPEA and suggest that you do with its stocks.
ORP2 reached its all-time high on Jun 5, 2024 with the price of 14.126 EUR, and its all-time low was 4.684 EUR and was reached on Dec 17, 2024. View more price dynamics on ORP2 chart.
See other stocks reaching their highest and lowest prices.
ORP2 stock is 5.34% volatile and has beta coefficient of 1.83. Track ORPEA stock price on the chart and check out the list of the most volatile stocks — is ORPEA there?
Yes, you can track ORPEA financials in yearly and quarterly reports right on TradingView.
ORPEA is going to release the next earnings report on May 9, 2025. Keep track of upcoming events with our Earnings Calendar.
As of Apr 17, 2025, the company has ‪78.48 K‬ employees. See our rating of the largest employees — is ORPEA on this list?
Like other stocks, ORP2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORPEA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORPEA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORPEA stock shows the strong buy signal. See more of ORPEA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.